Stacy Hurt | Chief Patient Officer
Parexel

Stacy ensures that patients and caregivers have a seat at the table to translate their lived experience and recommendations into improvements in the drug development process at its earliest stages. She brings a unique perspective as a stage IV cancer survivor, caregiver to her son who has an ultra-rare genetic chromosome abnormality, and a global patient advocate. Formerly Parexel’s Patient Ambassador, Stacy uses her voice to represent patients everywhere, even when they are not in the room. Her highly sought after insights shape strategies for clinical trial design and delivery. She’s an award-winning 25-year pharma executive with experience in functional areas such as sales, marketing, training, operations, and physician practice management. She is a frequent conference speaker and industry influencer, always championing patient involvement in clinical research, for example, as a member of the Global Annual Meeting Program Committee for Drug Information Association (DIA). She has also been honored by PM 360 as one of their ELITE 100 (Patient Advocate category) and by Fierce Pharma as one of their “Fierce 50” (Patient Advocacy category). Stacy holds a bachelor’s degree in labor and industrial relations from Penn State University and master’s degrees in health administration and business administration from the University of Pittsburgh.